sublocade
sublocade: sourced relationships with 1 company · 3 clinical trials tracked.
sublocade evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could sublocade → INDV affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) Moderate to Severe Opioid Use Disorder; Opioid-use Disorder;… | Phase 4 |
Clinical Trial Registry Records (3)
An Open-label, Multicentre Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Repeated Doses of INDV-6001 in Adults With Moderate to Severe Opioid Use Disorder
Primary endpoint: Steady-state area under the plasma concentration-time curve over the dosing interval (AUCtau) of buprenorphine following INDV-6001 injection in the abdomen
An Open-label, Treatment Extension Study for the Rapid Initiation of Extended-Release Buprenorphine Subcutaneous Injection (SUBLOCADE™)
Primary endpoint: Treatment Emergent Adverse Event (TEAE) Occurrence
An Open-label, Rapid Initiation Study for Extended-Release Buprenorphine Subcutaneous Injection (SUBLOCADE)
Primary endpoint: Participants Who Experienced Any Precipitated Withdrawal Within One Hour After SUBLOCADE Administration
Frequently asked questions
Which companies have sourced relationships with sublocade?
sublocade has dated SEC/FDA relationship records for Indivior Pharmaceuticals, Inc..
How many clinical trials involve sublocade?
BioSniper tracks 3 clinical trials involving sublocade.